Zhengye Biotechnology Holding Limited (ZYBT) Stock Overview
Explore Zhengye Biotechnology Holding Limited’s financial performance, market position, analyst ratings, and future outlook.
Zhengye Biotechnology Holding Limited (ZYBT)
Key Financials
Key Financials
Market Cap
96.7M
P/E Ratio
-9.24
EPS (TTM)
$-0.22
ROE
-0.27%
ZYBT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Zhengye Biotechnology Holding Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ZYBT on the NASDAQ shows an RSI of 54.95, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Zhengye Biotechnology Holding Limited's NASDAQ-traded stock include a P/E ratio of -9.24 and a market capitalization of 96.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ZYBT on the NASDAQ.